Journal article
The incidence of invasive breast cancer among women prescribed testosterone for low libido
SR Davis, R Wolfe, H Farrugia, A Ferdinand, RJ Bell
Journal of Sexual Medicine | Published : 2009
Abstract
Introduction. Although the efficacy of testosterone for the treatment of hypoactive sexual desire disorder is well established, the effect of testosterone therapy on breast cancer risk remains uncertain. Aim. The incidence of invasive breast cancer among past and current testosterone users. Methods. Retrospective cohort study of 631 women ever treated with testosterone between January 1989 and December 2007 in a clinical endocrinology practice. Main Outcome Measure. The incidence of invasive breast cancer since first exposure, and the standardized incidence rate ratio (IRR) calculated using Australian age-specific incidence rates for 2005. Results. The mean age of the women at first exposure..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This study was funded by the National Health and Medical Research Council of Australia Grant No. 219279 and an unrestricted research grant from Procter and Gamble Pharmaceuticals.